Both in vivo and in vitro experiments in the current study revealed that acute and chronic OCA treatment upregulated Treg (Foxp3 and IL-10/IL10R) signals and maintaining the proliferation and contraction in cardiomyocytes in NASH mice heart. This evidence concerns the gene FOXP3 and metabolic dysfunction-associated steatohepatitis.